Marcus R J, Quon L M, Wade M E
Am J Hosp Pharm. 1981 Jun;38(6):858-61.
A retrospective study of the contributions of clinical pharmacists on a gynecological unit was undertaken, based on an examination of the clinical pharmacists' interventions in and recommendations for drug therapy. Intervention or recommendations were classified as to type and as to probable result had the pharmacist not intervened or made recommendations. Over an eight-month period, the clinical pharmacist intervened in or made recommendation in 227 instances (0.8% of all medication orders). It was considered that two of the orders would probably have caused death had they been carried out, six could have caused toxicity and possible death, and 39 could have led to serious toxicity. The quality of patient care seemed to have been positively affected by having the clinical pharmacist in the patient care area.
基于对临床药师在药物治疗方面的干预措施和建议的审查,对妇科病房临床药师的贡献进行了一项回顾性研究。干预措施或建议根据类型以及若药师未进行干预或提出建议可能产生的结果进行分类。在八个月的时间里,临床药师进行了227次干预或提出建议(占所有用药医嘱的0.8%)。据认为,其中两项医嘱若执行可能会导致死亡,六项可能会导致毒性反应甚至可能死亡,39项可能会导致严重的毒性反应。在患者护理区域配备临床药师似乎对患者护理质量产生了积极影响。